Purdue Pharma Inks Draft Deal, Seeks Mediation Extension
OxyContin maker Purdue Pharma LP has inked a 50-page term sheet and 75-page draft master settlement agreement that could resolve its more than 5-year-old bankruptcy case after its last plan was...To view the full article, register now.
Already a subscriber? Click here to view full article